Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double‐blind placebo‐controlled trial

Overview of attention for article published in Clinical and Translational Allergy, December 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

So far, Altmetric has seen 28 X posts from 21 X users, with an upper bound of 46,148 followers.

RT @EAACI_HQ: #CTA_journal published a research that support the use of house dust mite AIT in elderly patients with #AllergicRhinitis http…

RT @EAACI_HQ: #CTA_journal published a research that support the use of house dust mite AIT in elderly patients with #AllergicRhinitis http…

RT @PhilAllergie: Et pendant ce temps, en France, on veut dérembourser https://t.co/8pangPTFFv

Et pendant ce temps, en France, on veut dérembourser https://t.co/8pangPTFFv

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 24 additional X posts.